Here's an interesting comparison of this year's preso vs last year's:
Slater has gone substantially backwards (no surprises). MB has still 9% market share. Shine has 1% less share than last year. Given Shine's WIP has increased I assume this is because the market itself has grown.
This means that MB has done a better job than Shine at gaining a slice of new business.
- Forums
- ASX - By Stock
- Ann: 2018 Annual Report
Here's an interesting comparison of this year's preso vs last...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SHJ (ASX) to my watchlist
(20min delay)
|
|||||
Last
86.0¢ |
Change
-0.015(1.71%) |
Mkt cap ! $148.9M |
Open | High | Low | Value | Volume |
86.0¢ | 86.0¢ | 86.0¢ | $2.19K | 2.546K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8488 | 86.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
87.0¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8488 | 0.860 |
1 | 10000 | 0.850 |
1 | 10000 | 0.810 |
2 | 3474 | 0.800 |
1 | 948 | 0.740 |
Price($) | Vol. | No. |
---|---|---|
0.870 | 10000 | 1 |
0.875 | 348 | 1 |
0.880 | 3410 | 1 |
0.890 | 44140 | 1 |
0.900 | 25834 | 3 |
Last trade - 15.58pm 12/11/2024 (20 minute delay) ? |
Featured News
SHJ (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online